Patricia K. DONAHOE

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Use of Mullerian inhibiting substance (MIS) proteins for contracept...
- Patent number 11,998,590
- Issue date Jun 4, 2024
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mullerian inhibiting substance (MIS) proteins for ovarian and uteri...
- Patent number 11,518,793
- Issue date Dec 6, 2022
- The General Hospital Corporation
- Patricia K. Donahoe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of mullerian inhibiting substance (MIS) proteins for contracept...
- Patent number 11,135,269
- Issue date Oct 5, 2021
- The General Hospital Corporation
- Patricia K. Donahoe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified Mullerian inhibiting substance (MIS) proteins and uses the...
- Patent number 11,084,860
- Issue date Aug 10, 2021
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Viral vectors for expressing a modified mullerian inhibiting substa...
- Patent number 10,258,668
- Issue date Apr 16, 2019
- The General Hospital Corporation
- Patricia K. Donahoe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Ovarian cancer stem cells and methods of isolation and uses thereof
- Patent number 9,791,449
- Issue date Oct 17, 2017
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Collecting ovarian cancer stem cells from ovarian cancer cells
- Patent number 9,289,492
- Issue date Mar 22, 2016
- The General Hospital Corporation
- Patricia K Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazoloanthrone and derivatives thereof for the treatment of cance...
- Patent number 9,260,759
- Issue date Feb 16, 2016
- The General Hospital Corporation
- Jose Teixeira
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Delivery of therapeutic biologicals from implantable tissue matrices
- Patent number 7,078,032
- Issue date Jul 18, 2006
- The General Hospital Corporation
- David T. MacLaughlin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Delivery of therapeutic biologicals from implantable tissue matrices
- Patent number 6,692,738
- Issue date Feb 17, 2004
- The General Hospital Corporation
- David T. MacLaughlin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of Mullerian inhibiting substance for treating excess androgen...
- Patent number 6,673,352
- Issue date Jan 6, 2004
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for enhancing cellular response to TGF-.be...
- Patent number 5,912,224
- Issue date Jun 15, 1999
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of mullerian inhibiting substance for treating certain tumors a...
- Patent number 5,661,126
- Issue date Aug 26, 1997
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding a receptor for Mullerian inhibitory substance, misr1,...
- Patent number 5,547,854
- Issue date Aug 20, 1996
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding a TGF-.beta. type 1 receptor
- Patent number 5,538,892
- Issue date Jul 23, 1996
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition comprising Mullerian inhibiting substance-like polypept...
- Patent number 5,427,780
- Issue date Jun 27, 1995
- Biogen, Inc.
- Richard L. Cate
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purification of Mullerian inhibiting substance
- Patent number 5,310,880
- Issue date May 10, 1994
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of mullerian inhibiting substance and its agonists and antagoni...
- Patent number 5,198,420
- Issue date Mar 30, 1993
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA sequences, recombinant DNA molecules and processes for producin...
- Patent number 5,047,336
- Issue date Sep 10, 1991
- Biogen, Inc.
- Richard L. Cate
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purified Mullerian inhibiting substance and process for treating hu...
- Patent number 5,011,687
- Issue date Apr 30, 1991
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of EGF to reverse the contraceptive activity of MIS
- Patent number 5,010,055
- Issue date Apr 23, 1991
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibody to mullerian inhibiting substance
- Patent number 4,792,601
- Issue date Dec 20, 1988
- The General Hospital Corporation
- Patricia K. Donahoe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of mullerian inhibiting substance as a contraceptive agent
- Patent number 4,753,794
- Issue date Jun 28, 1988
- The General Hospital Corporation
- Patricia Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purified Mullerian Inhibiting Substance and method of use
- Patent number 4,510,131
- Issue date Apr 9, 1985
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of preparing hybridomas and of purifying immunogenic materials
- Patent number 4,487,833
- Issue date Dec 11, 1984
- The General Hospital Corporation
- Patricia K. Donahoe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purified Mullerian Inhibiting Substance and method of purification
- Patent number 4,404,188
- Issue date Sep 13, 1983
- Massachusetts General Hospital
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR CONTRACEPT...
- Publication number 20240277812
- Publication date Aug 22, 2024
- The General Hospital Corporation
- Patricia K. DONAHOE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR PREVENTING OR DELAYING PUBERTY IN PREP...
- Publication number 20240218038
- Publication date Jul 4, 2024
- The General Hospital Corporation
- Patricia K. DONAHOE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR OVARIAN AND UTERI...
- Publication number 20240067692
- Publication date Feb 29, 2024
- The General Hospital Corporation
- Patricia K. DONAHOE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS AND USES THE...
- Publication number 20220041677
- Publication date Feb 10, 2022
- The General Hospital Corporation
- Patricia K. DONAHOE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR CONTRACEPT...
- Publication number 20200376082
- Publication date Dec 3, 2020
- The General Hospital Corporation
- Patricia K. DONAHOE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR OVARIAN AND UTERI...
- Publication number 20200071376
- Publication date Mar 5, 2020
- The General Hospital Corporation
- Patricia K. DONAHOE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR...
- Publication number 20190351026
- Publication date Nov 21, 2019
- The General Hospital Corporation
- Patricia K. DONAHOE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR CONTRACEPT...
- Publication number 20160310574
- Publication date Oct 27, 2016
- The General Hospital Corporation
- Patricia K. DONAHOE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
N-METHYL PYRAZOLOANTHRONE FOR TREATMENT OF CANCER
- Publication number 20160250190
- Publication date Sep 1, 2016
- The General Hospital Corporation
- David PEPIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR...
- Publication number 20160228514
- Publication date Aug 11, 2016
- The General Hospital Corporation
- Patricia K. DONAHOE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PYRAZOLOANTHRONE AND DERIVATIVES THEREOF FOR TREATMENT OF CANCERS E...
- Publication number 20160199352
- Publication date Jul 14, 2016
- The General Hospital Corporation
- Jose Teixeira
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS AND USES THE...
- Publication number 20160039898
- Publication date Feb 11, 2016
- The General Hospital Corporation
- Patricia K. DONAHOE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OVARIAN CANCER STEM CELLS AND METHODS OF ISOLATION AND USES THEREOF
- Publication number 20140194366
- Publication date Jul 10, 2014
- The General Hospital Corporation
- Patricia K. Donahoe
- G01 - MEASURING TESTING
Information Patent Application
PYRAZOLOANTHRONE AND DERIVATIVES THEREOF FOR TREATMENT OF CANCER AN...
- Publication number 20120141605
- Publication date Jun 7, 2012
- The General Hospital Corporation
- Jose Teixeira
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS TO IDENTIFY AND ENRICH FOR POPULATIONS OF OVARIAN CANCER ST...
- Publication number 20100273160
- Publication date Oct 28, 2010
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLOANTHRONE AND DERIVATIVES THEREOF FOR THE TREATMENT OF CANCE...
- Publication number 20100233689
- Publication date Sep 16, 2010
- The General Hospital Corporation
- Jose Teixeira
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of mullerian inhibiting substance and interferon for treating t...
- Publication number 20040151693
- Publication date Aug 5, 2004
- The General Hospital Corporation
- Shyamala Maheswaran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Delivery of therapeutic biologicals from implantable tissue matrices
- Publication number 20040086497
- Publication date May 6, 2004
- David T. MacLaughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of mullerian inhibiting substance for treating excess androgen...
- Publication number 20040062750
- Publication date Apr 1, 2004
- The General Hospital Corporation
- Patricia K. Donahoe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Delivery of therapeutic biologicals from implantable tissue matrices
- Publication number 20020031500
- Publication date Mar 14, 2002
- David T. MacLaughlin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patricia K. DONAHOE

Person

Patents Grantslast 30 patents

Use of Mullerian inhibiting substance (MIS) proteins for contracept...

Mullerian inhibiting substance (MIS) proteins for ovarian and uteri...

Use of mullerian inhibiting substance (MIS) proteins for contracept...

Modified Mullerian inhibiting substance (MIS) proteins and uses the...

Viral vectors for expressing a modified mullerian inhibiting substa...

Ovarian cancer stem cells and methods of isolation and uses thereof

Collecting ovarian cancer stem cells from ovarian cancer cells

Pyrazoloanthrone and derivatives thereof for the treatment of cance...

Delivery of therapeutic biologicals from implantable tissue matrices

Delivery of therapeutic biologicals from implantable tissue matrices

Use of Mullerian inhibiting substance for treating excess androgen...

Methods and compositions for enhancing cellular response to TGF-.be...

Use of mullerian inhibiting substance for treating certain tumors a...

DNA encoding a receptor for Mullerian inhibitory substance, misr1,...

Nucleic acids encoding a TGF-.beta. type 1 receptor

Composition comprising Mullerian inhibiting substance-like polypept...

Purification of Mullerian inhibiting substance

Use of mullerian inhibiting substance and its agonists and antagoni...

DNA sequences, recombinant DNA molecules and processes for producin...

Purified Mullerian inhibiting substance and process for treating hu...

Use of EGF to reverse the contraceptive activity of MIS

Monoclonal antibody to mullerian inhibiting substance

Use of mullerian inhibiting substance as a contraceptive agent

Purified Mullerian Inhibiting Substance and method of use

Method of preparing hybridomas and of purifying immunogenic materials

Purified Mullerian Inhibiting Substance and method of purification

Patents Applicationslast 30 patents

USE OF MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR CONTRACEPT...

COMPOSITIONS AND METHODS FOR PREVENTING OR DELAYING PUBERTY IN PREP...

MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR OVARIAN AND UTERI...

MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS AND USES THE...

USE OF MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR CONTRACEPT...

MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR OVARIAN AND UTERI...

USES OF MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR...

USE OF MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR CONTRACEPT...

N-METHYL PYRAZOLOANTHRONE FOR TREATMENT OF CANCER

USES OF MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR...

PYRAZOLOANTHRONE AND DERIVATIVES THEREOF FOR TREATMENT OF CANCERS E...

MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS AND USES THE...

OVARIAN CANCER STEM CELLS AND METHODS OF ISOLATION AND USES THEREOF

PYRAZOLOANTHRONE AND DERIVATIVES THEREOF FOR TREATMENT OF CANCER AN...

METHODS TO IDENTIFY AND ENRICH FOR POPULATIONS OF OVARIAN CANCER ST...

PYRAZOLOANTHRONE AND DERIVATIVES THEREOF FOR THE TREATMENT OF CANCE...

Use of mullerian inhibiting substance and interferon for treating t...

Delivery of therapeutic biologicals from implantable tissue matrices

Use of mullerian inhibiting substance for treating excess androgen...

Delivery of therapeutic biologicals from implantable tissue matrices